Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Male pattern baldness is largely genetic, linked to the androgen receptor gene, and may relate to certain health issues.

Hair growth and health are influenced by factors like age, environment, and nutrition, and are controlled by various molecular pathways. Red light can promote hair growth, and understanding these processes can help treat hair-related diseases.

High AMH levels are linked to PCOS in women and may have a male equivalent with similar traits.

High doses of nandrolone decanoate disrupt ovarian hormones and receptors in rats, with recovery only at lower doses and longer recovery times.

Retinoic acid affects male and female muscle energy use and function differently.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

Bald men may have a higher risk of heart disease, but baldness doesn't necessarily mean more severe heart disease.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

Accurate diagnosis of rare hyperandrogenism conditions requires detailed testing and sometimes invasive procedures.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

4-O-Methylhonokiol helps protect skin cells from growth-stopping effects of a protein by regulating growth-related pathways.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

Understanding hair follicles through various models can help develop new treatments for hair disorders.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Male mice with FGF5 mutations grow longer hair than females.

Antiandrogens may help prevent or treat COVID-19 by blocking virus entry into cells.